Abstract

OPTIC-2L: a Superiority Trial of Two Lower Doses of Ponatinib Versus Standard Dose Nilotinib in Second-Line Chronic Phase CML

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Hyperhomocysteinemia and High Doses of Nilotinib Favour Cardio-Vascular Events in Chronic Phase Chronic Myelogenous Leukemia (CML) Patients
Gaelle Fossard ... Franck E Nicolini
Blood | VOL. 124
Gaelle Fossard, et. al.Gaelle Fossard ... Franck E Nicolini
06 Dec 2014
Effective and Selective Elimination of CML Stem Cells Using Novel Ethacrynic Acid Derivatives
Su Chu ... Ravi Bhatia
Blood | VOL. 124
Su Chu, et. al.Su Chu ... Ravi Bhatia
06 Dec 2014
Genome-Wide Analysis of Genetic Alterations in Chronic Myelogenous Leukemia.
Charles G Mullighan ... James R Downing
Blood | VOL. 112
Charles G Mullighan, et. al.Charles G Mullighan ... James R Downing
16 Nov 2008
Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?
Daniel J Deangelo ... Jerome Ritz
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 10
Daniel J Deangelo, et. al.Daniel J Deangelo ... Jerome Ritz
01 Jan 2004
View more papers

More From: Clinical Lymphoma & Myeloma

Paper Title
Journal
Date
Author
Comparison of Laboratory Data at Initial Diagnosis of Multiple Myeloma Between Black Africans, African Americans and White patients
Lambert A Essiaw ... Lily Paemka
Clinical Lymphoma & Myeloma | VOL. -
Lambert A Essiaw, et. al.Lambert A Essiaw ... Lily Paemka
01 Jul 2024
Improving Access to T-Cell Therapies in Multiple Myeloma
Benjamin A Derman
Clinical Lymphoma & Myeloma | VOL. -
Benjamin A DermanBenjamin A Derman
01 Jul 2024
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib
Nico Gagelmann ... Bart Scott
Clinical Lymphoma & Myeloma | VOL. -
Nico Gagelmann, et. al.Nico Gagelmann ... Bart Scott
01 Jul 2024
Editorial Board
-
Clinical Lymphoma & Myeloma | VOL. 24
--
01 Jul 2024
View more papers